Fermiscan Holdings Limited (FER) - Financial and Strategic Analysis ReviewFermiscan Holdings Limited (Fermiscan) is a medical device company engaged in the development of products and technology for use in the detection and treatment of breast cancer. The company was formerly known as Olympus Resources Limited. The company is headquartered in Sydney, Australia. The company operates through the Fermiscan Test which is the commercialisation of non-invasive and simple breast cancer screening for women. The company licenses and sells the test in the markets of Australia, Europe, Japan, South East Asia, and the US. In March 2009, it was granted exclusive
More...
More...